D C Johannessen
Overview
Explore the profile of D C Johannessen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
1395
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lonning P, Helle S, Johannessen D, Adlercreutz H, Lien E, Tally M, et al.
Clin Endocrinol (Oxf)
. 1995 Jan;
42(1):23-30.
PMID: 7534218
Objective: Oestrogens, androgens and anti-endocrine drugs such as tamoxifen and aminoglutethimide influence plasma insulin-like growth factor-I (IGF-I). IGF-I, in turn, has been found to stimulate the peripheral aromatase in vitro....
12.
Johannessen D, Adlercreutz H, Fotsis T, Lonning P
Br J Cancer
. 1993 Aug;
68(2):393-8.
PMID: 8135918
Plasma and urinary oestrogens were measured in nine breast cancer patients (eight postmenopausal women and one man) before and during treatment with the aromatase inhibitor 4-hydroxyandrostenedione. Urinary oestrogens were measured...
13.
Johannessen D, Lonning P
Drugs Aging
. 1992 Nov;
2(6):530-45.
PMID: 1493356
Aromatase inhibition is an established endocrine treatment modality in postmenopausal breast cancer and is currently considered as an interesting experimental treatment approach in other malignant conditions such as endometrial carcinomas...
14.
Lien E, Johannessen D, AAKVAAG A, Lonning P
J Steroid Biochem Mol Biol
. 1992 Mar;
41(3-8):541-3.
PMID: 1532904
Plasma insulin-like growth factor-I (IGF-I) was measured in breast cancer patients before and during treatment with tamoxifen, goserelin or aminoglutethimide. 24 out of 27 postmenopausal women treated with tamoxifen 20...
15.
Lonning P, Dowsett M, Jones A, Ekse D, Jacobs S, McNeil F, et al.
Breast Cancer Res Treat
. 1992 Jan;
23(1-2):57-62.
PMID: 1446052
The clinical and biochemical effects of combined treatment with the two aromatase inhibitors aminoglutethimide and 4-hydroxyandrostenedione were evaluated in 10 patients suffering from advanced breast cancer. All patients had become...
16.
Lonning P, Johannessen D, Thorsen T, Ekse D
J Steroid Biochem
. 1989 Oct;
33(4A):541-5.
PMID: 2811363
Plasma levels of estrone and estrone sulfate were measured in 16 postmenopausal women with advanced breast cancer before and during chronic aminoglutethimide therapy. Aminoglutethimide caused a significant reduction in plasma...
17.
Lonning P, Johannessen D, Thorsen T
Br J Cancer
. 1989 Jul;
60(1):107-11.
PMID: 2553085
Plasma level, plasma clearance, production rate and interconversions of oestrone and oestrone sulphate were measured in six breast cancer patients receiving aminoglutethimide therapy. Three additional patients had the production rate...